Form 4: EverQuote CTO Sells Shares Under 10b5-1 Plan
Insider Transaction Report
EverQuote's Chief Technology Officer, David Brainard, sold 5,710 shares of Class A Common Stock for a weighted average price of $22.20 per share, pursuant to a pre-arranged 10b5-1 trading plan.
Summary
- David Brainard, Chief Technology Officer of EverQuote, Inc. (EVER), reported a sale of company stock.
- The transaction involved 5,710 shares of Class A Common Stock.
- The shares were sold on October 7, 2025, at a weighted average price of $22.20 per share.
- Individual sale prices ranged from $22.03 to $22.34.
- Following the sale, David Brainard beneficially owns 115,161 shares of Class A Common Stock.
- The sale was executed under a Rule 10b5-1 trading plan, which was adopted on March 17, 2025.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. While an insider sale could be seen negatively, the execution under a pre-arranged 10b5-1 plan mitigates concerns about opportunistic selling. The officer still holds a substantial number of shares.
Positives
- The sale was conducted under a Rule 10b5-1 trading plan, indicating a pre-scheduled transaction and reducing concerns about opportunistic insider selling.
- The reporting person still retains a significant holding of 115,161 shares after the transaction.
Negatives
- An insider sale, even under a 10b5-1 plan, can sometimes be perceived as a lack of confidence, though this is mitigated by the pre-arranged nature.
Risks
- No specific risks are mentioned in this Form 4 filing beyond the inherent market risks associated with stock ownership.
Future Outlook
NA
Industry Context
This Form 4 filing reports a routine insider transaction for EverQuote, Inc., a company operating in the online insurance marketplace. Such transactions are common across various industries as executives manage personal finances and diversify portfolios, especially when executed under pre-arranged 10b5-1 plans.
Comparison to Industry Standards
- NA
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Trading Plan Adoption | David Brainard adopted a Rule 10b5-1 trading plan on March 17, 2025, which allows insiders to set up a pre-scheduled plan for buying or selling company stock to avoid accusations of insider trading. | 03/17/2025 | Enhances transparency and provides an affirmative defense against insider trading allegations for the reported transaction. |
Stakeholder Impact
- Shareholders: The sale represents a minor dilution of ownership for existing shareholders, but the pre-arranged nature under a 10b5-1 plan generally minimizes negative sentiment. The officer retains a significant stake, aligning interests.
Next Steps
- The reporting person undertakes to provide EverQuote, Inc., any security holder, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the reported range.
Key Dates
| Date | Description |
|---|---|
| 03/17/2025 | Date Rule 10b5-1 trading plan was adopted by David Brainard. |
| 10/07/2025 | Date of the reported stock transaction (sale of Class A Common Stock). |
| 10/09/2025 | Date the Form 4 filing was signed. |
Recommendation
holdThis Form 4 reports a routine insider stock sale executed under a pre-arranged 10b5-1 trading plan. Such transactions are typically for personal financial management and diversification and do not usually signal a change in the company's fundamental outlook or warrant a strong buy or sell recommendation. The officer retains a substantial holding, suggesting continued alignment with shareholder interests. Investors should consider broader company fundamentals and market conditions rather than this single transaction for investment decisions.
Keywords
EverQuote, EVER, David Brainard, Chief Technology Officer, CTO, Form 4, Insider Trading, Stock Sale, 10b5-1 Plan, Equity Transaction, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.